ac22 - session iii :: targeted therapies and overcoming resistance
Published 2 years ago • 227 plays • Length 1:31:06Download video MP4
Download video MP3
Similar videos
-
35:30
ac22 - cholangiocarcinoma updates panel discussion
-
1:51:39
ac22 - session vi :: multi-disciplinary case-based discussion
-
18:20
ac22 - clinical update
-
1:05:02
ac22 - session ii :: studying the neighborhood: lessons from the tumor microenvironment
-
11:05
ac22 - clonal origins of metastatic cholangiocarcinoma
-
26:50
ac22 - topaz-1 trial in biliary tract cancer
-
10:39
ac22 - explore signaling pathways and combination therapy in fgfr2-activated cholangiocarcinoma
-
1:14:36
webinar: targeted treatment strategies for advanced cholangiocarcinoma -results of promising trials
-
0:55
targeted therapy options for cholangiocarcinoma
-
19:15
ac22 - scientific update
-
9:59
ac22 - deciphering the role of cancer-associated myeloid cells in resistance to immunotherapy
-
1:00:01
webinar: targeting the fgfr pathway: infigratinib in cholangiocarcinoma
-
1:12:06
ac22 - session iv :: epigenetics: now or never?
-
10:53
ac22 - deep immune profiling of intrahepatic cholangiocarcinoma with codex multiplexed imaging
-
1:53:47
ac23 - session iii: immunotherapy: where we are and where we're going?
-
10:07
ac21 - arndt vogel: management of perihilar cholangiocarcinoma - medical oncology
-
12:33
ac21 - shubham pant: targeting her2 in biliary tract cancers
-
4:51
bile duct cancer (cholangiocarcinoma), causes, signs and symptoms, diagnosis and treatment.